ALLISON INSTITUTE

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ALLISON INSTITUTE was filed as Word mark on 09/22/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/03/2024. The current status of the mark is "Trademark registered".

Trademark Details Last update: March 6, 2024

Trademark form Word mark
File reference 018765440
Application date September 22, 2022
Publication date December 14, 2022
Entry date January 3, 2024
Expiration date September 22, 2032

Trademark owner

210 West 7th Street
78701 Austin
US

Trademark representatives

Objection / Complaint

03/14/2023: Likelihood of confusion Unfair advantage /detriment to distinctiveness or repute
Applicant
Capernaum Limited

goods and services

35 Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease; collection and management of medical and scientific data in the field of medical and scientific research; all the foregoing offered in relation to a cancer treatment or cancer research facility
41 Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy; all the foregoing offered in relation to a cancer treatment or cancer research facility
42 Medical research services; research, development, technical design, testing, consulting and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology
44 Medical and pharmaceutical services; medical and pharmaceutical services relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care and cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions

Trademark history

Date Document number Area Entry
March 5, 2024 Change Representative, Published

ID: 11018765440